NAD Recommends P&G Discontinue ‘100% Odor Protection’ Claim for Secret ‘Clinical Strength,’ Finds Certain Claims Supported

New York, NY – Oct. 30,  2014 – The National Advertising Division has recommended that The Procter & Gamble Company discontinue certain claims for the company’s “Secret Clinical Strength” antiperspirant/deodorant products, including claims of “100% odor protection.”

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

Claims, including those made in television, print, and social media advertising, as well as on the company website, were challenged by Unilever United States, Inc., the maker of competing antiperspirants/deodorants.

NAD examined express claims for “Secret Clinical Strength Clear Gel” and “Secret Clinical Strength Invisible Solid” that included:

  • “100% odor protection” for products labeled with a “48 hour odor protection” claim.
  • “100% odor protection* *as typically noticed by others.”
  • “#100% or Nothing”

NAD considered also whether the advertising implied that:

  • Secret Clinical Strength products are clinically proven to provide complete protection from underarm odor for 48 hours for 100% of women in 100% of circumstances, including after enduring stress, physical activity, and heat.

The challenged claim “100% odor protection*” appeared with the disclosure  “*as typically noticed by others,” and was featured in a television commercial and in print, web, and social media advertising.

The broadcast advertising depicted a young executive preparing for an important meeting and the voiceover stated: “The day of my first presentation I was 80% nervous to lead the meeting, 90% confident I’d say the right things, but with 100% odor protection, I knew I had nothing to worry about.”

In conjunction with the voiceover, the text “80% nervous,” “90% confident,” and “100% odor protection” appeared in large print over the center of the screen. The disclaimer “*as typically noticed by others,” appeared in significantly smaller type at the bottom.

The voiceover continued: “The new Secret Clinical Strength Collection has the unique, high-efficiency technology that helps eliminate odor for 100% odor protection,” and the “100% odor protection” claim appeared on screen again with the disclaimer. Finally, the voiceover stated: “I never settle for less than 100% so I can be 100% fearless.”

The challenger argued that the claim was a strong quantified performance claim that should be read in conjunction with the “48 hour protection” claim on the packaging. It contended that the advertiser’s claim conveyed the message that no person using the product would emit any underarm malodor for two full days. The advertiser argued that the “100% odor protection” claim as presented was used colloquially, in the context of a play on percentages in its television commercial and advertising campaign. Neither party provided consumer perception evidence to support its position regarding how consumers were likely to interpret the challenged claims.

NAD determined that the claim conveyed a message of “objective certainty,” and that consumers could quite reasonably understand the claim to mean that they would not emit any underarm odor when using Secret Clinical Strength.

Regarding the advertiser’s disclosure, NAD noted that even if consumers noticed, read, and understood the phrase, “as typically noticed by others,” they would not necessarily understand that the promised 100% odor protection would only be provided in some, and not “100%,” of situations.

Following its review of the advertiser’s evidence, NAD noted that the advertiser’s testing demonstrated the high level of overall effectiveness of Secret Clinical Strength, but determined that its test results were not sufficient to provide a reasonable basis for P&G’s quantified and absolute “100% odor protection” claim. NAD recommended that the claim be discontinued.

NAD noted its appreciation for P&G’s permanent discontinuance of certain versions of the challenged claims, some of which it noted were made in error.

NAD found that the advertiser provided a reasonable basis for its claim, “Unlike smooth solid clinical strength antiperspirants which can leave white marks behind, Secret Clinical Strength Clear Gel goes on clear with no white marks,” but that its broader “Clear Gel – For a Clean No White Marks Look” claim was not adequately supported. NAD recommended that this version of the claim be discontinued.

Finally, NAD determined that a “Doctor Recommended” claim challenged by Unilever was not substantiated and recommended that the claim be discontinued or modified to reflect that the product is “Doctor Endorsed.”

P&G, in its advertiser’s statement, said that although the company “does not agree with all of NAD’s conclusions, it is pleased that NAD generally recognizes the product’s superior efficacy, and P&G will take NAD’s recommendations into account in future advertising.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary